Clinical Trial Update: Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating risperidone and olanzapine for schizophrenia patients with neuroleptic-induced acute dystonia or Parkinsonism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapyramidal Symptoms
• Schizophrenia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• olanzapine (olanzapine)

Snippet

Sponsor: Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan | Conditions: Schizophrenia, Extrapyramidal Syndrome | Phase 4 | Status: COMPLETED